Bioliberty Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $11.8M

  • Investors
  • 17

Bioliberty General Information

Description

Operator of a biotechnology and medical technology company intended to develop robotic gloves using artificial intelligence for muscle recovery. The company uses assistive robotics and rehabilitative devices that allow users with stroke, motor neuron disease, multiple sclerosis, rheumatoid arthritis, and osteoarthritis to handle hand weakness, enabling patients to handle and improve strength for daily tasks and develop hand strength to live comfortably in their homes.

Contact Information

Website
www.bioliberty.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Third floor, Canning Exchange
  • 10 Canning Street
  • Edinburgh EH3 8EG
  • Scotland, United Kingdom
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Wearables & Quantified Self, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Third floor, Canning Exchange
  • 10 Canning Street
  • Edinburgh EH3 8EG
  • Scotland, United Kingdom

Bioliberty Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioliberty Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series A) 02-Nov-2026 $11.8M Completed Generating Revenue
13. Later Stage VC 22-Apr-2025 Completed Generating Revenue
12. Grant 04-Dec-2023 Completed Generating Revenue
11. Early Stage VC 31-Mar-2023 Completed Generating Revenue
10. Accelerator/Incubator 04-Aug-2022 Completed Generating Revenue
9. Grant 04-Aug-2022 Completed Generating Revenue
8. Seed Round 01-Jan-2022 Completed Generating Revenue
7. Grant 01-Oct-2021 Completed Generating Revenue
6. Seed Round 16-Feb-2021 Cancelled Generating Revenue
5. Accelerator/Incubator 01-Feb-2021 Completed Generating Revenue
To view Bioliberty’s complete valuation and funding history, request access »

Bioliberty Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view Bioliberty’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Bioliberty Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

Bioliberty Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202502820-D0 Device and method for assisting movement of a body part Pending 26-Feb-2025
WO-2026180556-A1 Device and method for assisting movement of a body part Pending 26-Feb-2025
WO-2026180507-A1 Wearable assistive article Pending 26-Feb-2025
GB-202502822-D0 Wearable assistive device Pending 26-Feb-2025
GB-2705440-A Wearable assistive device Pending 26-Feb-2025 A61H1/0288
To view Bioliberty’s complete patent history, request access »

Bioliberty Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioliberty Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
25m Health Venture Capital Minority
Ballad Ventures Corporate Venture Capital Minority
Conduit Connect Impact Investing Minority
TGH Ventures Corporate Venture Capital Minority
The Scottish National Investment Bank Investment Bank Minority
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial

Bioliberty FAQs

  • When was Bioliberty founded?

    Bioliberty was founded in 2020.

  • Where is Bioliberty headquartered?

    Bioliberty is headquartered in Edinburgh, United Kingdom.

  • What is the size of Bioliberty?

    Bioliberty has 34 total employees.

  • What industry is Bioliberty in?

    Bioliberty’s primary industry is Therapeutic Devices.

  • Is Bioliberty a private or public company?

    Bioliberty is a Private company.

  • What is Bioliberty’s current revenue?

    The current revenue for Bioliberty is .

  • How much funding has Bioliberty raised over time?

    Bioliberty has raised $16.9M.

  • Who are Bioliberty’s investors?

    25m Health, Ballad Ventures, Conduit Connect, TGH Ventures, and The Scottish National Investment Bank are 5 of 17 investors who have invested in Bioliberty.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process